(VIANEWS) – Shares of Teva Pharmaceutical (NYSE Composite: TEVA) slid 5.48% to $9.57 at 10:46 EST on Tuesday, after five consecutive sessions in a row of losses. NYSE Composite is rising 0.15% to $17,195.16, after two consecutive sessions in a row of gains. This seems, up until now, a somewhat up trend trading session today.

Teva Pharmaceutical’s last close was $9.22, 30.68% below its 52-week high of $13.30.


Today’s last reported volume for Teva Pharmaceutical is 7207418 which is 8.18% below its average volume of 7849929.

Teva Pharmaceutical’s Sales

Teva Pharmaceutical’s sales growth is 1.3% for the present quarter and a decline by 3.5% for the next. The company’s growth estimates for the current quarter and the next is 12.1% and 7.4%, respectively.

Teva Pharmaceutical’s Revenue

Year-on-year quarterly revenue growth grew by 1%, now sitting on 16.32B for the twelve trailing months.

Teva Pharmaceutical’s Stock Yearly Top and Bottom Value

Teva Pharmaceutical’s stock is valued at $9.57 at 10:46 EST, way under its 52-week high of $13.30 and way above its 52-week low of $8.24.

Teva Pharmaceutical’s Moving Average

Teva Pharmaceutical’s worth is above its 50-day moving average of $9.54 and below its 200-day moving average of $9.91.

More news about Teva Pharmaceutical (TEVA).


Please enter your comment!
Please enter your name here